• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

受体酪氨酸激酶的上下文相关调控:系统生物学方法的见解。

Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.

机构信息

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland.

Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland.

出版信息

Wiley Interdiscip Rev Syst Biol Med. 2019 Mar;11(2):e1437. doi: 10.1002/wsbm.1437. Epub 2018 Sep 26.

DOI:10.1002/wsbm.1437
PMID:30255986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6537588/
Abstract

Receptor tyrosine kinases (RTKs) are cell membrane proteins that provide cells with the ability to sense proteins in their environments. Many RTKs are essential to development and organ growth. Derangement of RTKs-by mutation or by overexpression-is central to several developmental and adult disorders including cancer, short stature, and vascular pathologies. The mechanism of action of RTKs is complex and is regulated by contextual components, including the existence of multiple competing ligands and receptors in many families, the intracellular location of the RTK, the dynamic and cell-specific coexpression of other RTKs, and the commonality of downstream signaling pathways. This means that both the state of the cell and the microenvironment outside the cell play a role, which makes sense given the pivotal location of RTKs as the nexus linking the extracellular milieu to intracellular signaling and modification of cell behavior. In this review, we describe these different contextual components through the lens of systems biology, in which both computational modeling and experimental "omics" approaches have been used to better understand RTK networks. The complexity of these networks is such that using these systems biology approaches is necessary to get a handle on the mechanisms of pathology and the design of therapeutics targeting RTKs. In particular, we describe in detail three concrete examples (involving ErbB3, VEGFR2, and AXL) that illustrate how systems approaches can reveal key mechanistic and therapeutic insights. This article is categorized under: Biological Mechanisms > Cell Signaling Models of Systems Properties and Processes > Mechanistic Models Translational, Genomic, and Systems Medicine > Therapeutic Methods.

摘要

受体酪氨酸激酶(RTKs)是细胞膜蛋白,使细胞能够感知其环境中的蛋白质。许多 RTKs 对发育和器官生长至关重要。RTKs 的失调——通过突变或过度表达——是几种发育和成人疾病(包括癌症、身材矮小和血管病理学)的核心。RTKs 的作用机制复杂,受上下文成分的调节,包括许多家族中存在多种竞争配体和受体、RTK 的细胞内位置、其他 RTKs 的动态和细胞特异性共表达以及下游信号通路的共性。这意味着细胞的状态和细胞外的微环境都起着作用,这是有意义的,因为 RTKs 作为连接细胞外环境与细胞内信号转导和细胞行为改变的枢纽,处于关键位置。在这篇综述中,我们通过系统生物学的视角描述了这些不同的上下文成分,其中计算建模和实验“组学”方法都被用于更好地理解 RTK 网络。这些网络的复杂性使得使用这些系统生物学方法对于理解病理学机制和设计针对 RTKs 的治疗方法是必要的。特别是,我们详细描述了三个具体的例子(涉及 ErbB3、VEGFR2 和 AXL),说明了系统方法如何揭示关键的机制和治疗见解。本文属于以下类别: 生物机制 > 细胞信号 系统特性和过程的模型 > 机制模型 转化、基因组和系统医学 > 治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/4dc0b0a6e2d7/nihms-986528-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/9c0b19e9aafc/nihms-986528-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/f93554c30650/nihms-986528-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/4dc0b0a6e2d7/nihms-986528-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/9c0b19e9aafc/nihms-986528-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/f93554c30650/nihms-986528-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e22/6537588/4dc0b0a6e2d7/nihms-986528-f0004.jpg

相似文献

1
Context-dependent regulation of receptor tyrosine kinases: Insights from systems biology approaches.受体酪氨酸激酶的上下文相关调控:系统生物学方法的见解。
Wiley Interdiscip Rev Syst Biol Med. 2019 Mar;11(2):e1437. doi: 10.1002/wsbm.1437. Epub 2018 Sep 26.
2
The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.受体 AXL 使 EGFR 信号多样化,并限制三阴性乳腺癌细胞对 EGFR 靶向抑制剂的反应。
Sci Signal. 2013 Aug 6;6(287):ra66. doi: 10.1126/scisignal.2004155.
3
Novel tyrosine kinase signaling pathways: implications in vascular remodeling.新型酪氨酸激酶信号通路:对血管重构的影响。
Curr Opin Nephrol Hypertens. 2012 Mar;21(2):122-7. doi: 10.1097/MNH.0b013e3283503ce9.
4
Transcriptional activation of the Axl and PDGFR-α by c-Met through a ras- and Src-independent mechanism in human bladder cancer.人膀胱癌中 c-Met 通过一种独立于 ras 和 Src 的机制激活 Axl 和 PDGFR-α 的转录。
BMC Cancer. 2011 Apr 16;11:139. doi: 10.1186/1471-2407-11-139.
5
Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells.AXL受体激酶的调节性膜内蛋白水解产生一个定位于癌细胞细胞核的细胞内结构域。
FASEB J. 2017 Apr;31(4):1382-1397. doi: 10.1096/fj.201600702R. Epub 2016 Dec 29.
6
Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis.导致肿瘤发生的酪氨酸激酶受体激活的信号转导通路。
Oncogene. 1998 Sep 17;17(11 Reviews):1343-52. doi: 10.1038/sj.onc.1202171.
7
Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.肿瘤相关巨噬细胞(TAM)受体后信号传导的正常化揭示了Axl酪氨酸激酶的细胞侵袭特征。
Cell Commun Signal. 2016 Sep 6;14(1):19. doi: 10.1186/s12964-016-0142-1.
8
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.间皮瘤中多种受体酪氨酸激酶的靶向抑制。
Neoplasia. 2011 Jan;13(1):12-22. doi: 10.1593/neo.101156.
9
Galectin-3 Stimulates Tyro3 Receptor Tyrosine Kinase and Erk Signalling, Cell Survival and Migration in Human Cancer Cells.半乳糖凝集素-3 可刺激酪氨酸 3 受体酪氨酸激酶和 Erk 信号转导、细胞存活和人类癌细胞迁移。
Biomolecules. 2020 Jul 11;10(7):1035. doi: 10.3390/biom10071035.
10
Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer.Gas6/Axl 信号通路在癌症治疗中的靶向作用。
Int J Mol Sci. 2021 Sep 15;22(18):9953. doi: 10.3390/ijms22189953.

引用本文的文献

1
Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities.计算膜蛋白作为抗癌靶点的特征:当前的挑战和机遇。
Int J Mol Sci. 2024 Mar 26;25(7):3698. doi: 10.3390/ijms25073698.
2
Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.受体酪氨酸激酶:抑制血管平滑肌细胞增殖的仍然有趣的靶点。
Am J Cardiovasc Drugs. 2023 Sep;23(5):497-518. doi: 10.1007/s40256-023-00596-3. Epub 2023 Jul 31.
3
Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies.

本文引用的文献

1
Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease.表皮生长因子受体在生理与疾病中的表达及功能
Physiol Rev. 2016 Jul;96(3):1025-1069. doi: 10.1152/physrev.00030.2015.
2
EGFR family and Src family kinase interactions: mechanics matters?表皮生长因子受体家族和Src 家族激酶相互作用:力学因素重要吗?
Curr Opin Cell Biol. 2018 Apr;51:97-102. doi: 10.1016/j.ceb.2017.12.003. Epub 2017 Dec 28.
3
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).
联合靶向血管内皮生长因子和分化簇47信号通路的多激酶酪氨酸激酶抑制剂预计可提高抗血管生成联合疗法的疗效。
ACS Pharmacol Transl Sci. 2023 Apr 18;6(5):710-726. doi: 10.1021/acsptsci.3c00008. eCollection 2023 May 12.
系统生物学推动药物研发:从抗ErbB3抗体seribantumab(MM - 121)的设计到临床试验
NPJ Syst Biol Appl. 2017 Jan 5;3:16034. doi: 10.1038/npjsba.2016.34. eCollection 2017.
4
Dynamic alterations in decoy VEGF receptor-1 stability regulate angiogenesis.动态改变诱饵血管内皮生长因子受体-1 的稳定性调节血管生成。
Nat Commun. 2017 Jun 7;8:15699. doi: 10.1038/ncomms15699.
5
A computational analysis of in vivo VEGFR activation by multiple co-expressed ligands.多种共表达配体对体内血管内皮生长因子受体(VEGFR)激活作用的计算分析
PLoS Comput Biol. 2017 Mar 20;13(3):e1005445. doi: 10.1371/journal.pcbi.1005445. eCollection 2017 Mar.
6
Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling.血小板衍生生长因子受体β(PDGFRβ)的多种内吞内化途径有助于血小板衍生生长因子(PDGF)诱导的信号转导和转录激活因子3(STAT3)信号传导。
J Cell Sci. 2017 Feb 1;130(3):577-589. doi: 10.1242/jcs.191213. Epub 2016 Dec 15.
7
Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2.内皮细胞受体酪氨酸激酶VEGFR-2的位点特异性N-糖基化
J Proteome Res. 2017 Feb 3;16(2):677-688. doi: 10.1021/acs.jproteome.6b00738. Epub 2016 Dec 29.
8
Mechanisms and regulation of endothelial VEGF receptor signalling.内皮细胞 VEGF 受体信号转导的机制和调控。
Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25. doi: 10.1038/nrm.2016.87. Epub 2016 Jul 27.
9
Spatial and Temporal Regulation of Receptor Tyrosine Kinase Activation and Intracellular Signal Transduction.受体酪氨酸激酶激活和细胞内信号转导的时空调控。
Annu Rev Biochem. 2016 Jun 2;85:573-97. doi: 10.1146/annurev-biochem-060815-014659. Epub 2016 Mar 24.
10
A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response.一种可阻断配体依赖性和非依赖性活性的强效HER3单克隆抗体:PTEN状态对肿瘤反应的不同影响。
Mol Cancer Ther. 2016 Apr;15(4):689-701. doi: 10.1158/1535-7163.MCT-15-0555. Epub 2016 Feb 15.